리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 10월
페이지 정보:영문 194 Pages
라이선스 & 가격 (부가세 별도)
한글목차
환자 등록 소프트웨어 시장은 2030년까지 38억 달러에 이를 것으로 예상됩니다.
2023년에 17억 달러로 추정된 환자 등록 소프트웨어 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 11.7%로 성장하고, 2030년에는 38억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 제품 레지스트리는 복합 연간 성장률(CAGR) 11.0%로 성장을 지속하고, 분석 기간이 끝날 때 9억 9,290만 달러에 도달할 것으로 예측됩니다. 의료 서비스 등록(Health Service Registries) 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 11.2%로 추정됩니다.
미국 시장은 4억 6,610만 달러, 중국은 복합 연간 성장률(CAGR) 10.9%로 성장할 것으로 예측됩니다.
미국 환자 등록 소프트웨어 시장은 2023년 4억 6,610만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2023년부터 2030년의 분석 기간에 복합 연간 성장률(CAGR) 10.9%로 성장을 지속하여 2030년까지 5억 7,560만 달러 규모에 이를 것으로 예측되고 있습니다. 다른 주목할만한 지리적 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 복합 연간 성장률(CAGR)은 각각 10.3%와 9.9%로 예측됩니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 약 8.5%로 성장할 것으로 예측됩니다.
세계 환자 등록 소프트웨어 시장 - 주요 동향 및 촉진요인 요약
기술은 환자 등록 소프트웨어 시장에 어떤 혁명을 가져올 것인가?
환자 등록 소프트웨어 시장은 기술의 진보로 의료기관이 엄청난 양의 환자 데이터를 보다 효율적으로 수집, 분석 및 활용할 수 있게 하여 큰 변화를 맞이하고 있습니다. 전통적으로 환자 등록은 수동 또는 종이 기반 시스템이었으며 데이터의 정확성, 접근성 및 확장성에 어려움이 있었습니다. 오늘날 클라우드 기반 환자 등록 소프트웨어 솔루션은 환자 데이터를 관리하는 방법에 혁명을 일으켜 의료 제공업체에게 종합적인 데이터베이스에 실시간 액세스를 제공합니다. 이러한 시스템은 인구통계, 치료, 결과, 심지어 유전 정보에 대한 구조화된 데이터의 수집을 가능하게 하고, 의료 제공업체는 환자 결과를 개선하기 위한 정보에 기초한 의사 결정을 내릴 수 있습니다. 할 수 있습니다. 또한 이러한 소프트웨어 솔루션에 인공지능(AI) 및 머신러닝(ML) 알고리즘을 통합함으로써 예측 분석 기능이 강화되어 질병의 조기 발견, 치료 효과 분석, 환자의 개별 케어 전략이 가능 됩니다. 이러한 기술 변화는 병원과 연구 기관의 업무를 간소화할 뿐만 아니라 공중 보건 모니터링과 임상 연구의 진보로 이어지고 있습니다.
의료기관이 환자 등록 소프트웨어를 채택하는 이유
환자 등록 소프트웨어의 채택은 환자의 결과를 추적하고, 치료 효과를 모니터링하고, 규제 요구 사항을 준수하는 능력을 향상시키기 위해 의료 기관에 점점 더 중요 해지고 있습니다. 병원, 연구 기관 및 전문 클리닉은 만성 질환 환자 관리, 임상시험 참가자 추적, 집단 헬스케어를 위한 데이터 수집에 레지스트리 소프트웨어를 활용합니다. 이러한 시스템을 통해 의료 제공업체는 암, 당뇨병 또는 심혈관 질환과 같은 질병별 레지스트리를 구축할 수 있어 상세한 추적 및 분석을 통해 환자 관리 최적화를 보장합니다. 또한, 환자 등록 소프트웨어를 사용하여 의료 기관은 환자 정보의 안전하고 규정 준수에 따른 보존을 보장함으로써 미국 HIPAA 및 유럽 GDPR(EU 개인정보보호규정)과 같은 다양한 규정을 준수할 수 있습니다. 레지스트리 데이터를 규제기관이나 연구기관과 공유할 수 있게 됨으로써 의료 에코시스템 전체의 협업을 촉진하는 시스템의 역할이 더욱 높아지고 있습니다. 환자 등록 소프트웨어는 데이터 수집 및 보고를 간소화하여 임상 의사결정과 환자에게 제공되는 치료 전반의 질 향상에 기여합니다.
소비자와 업계의 추세는 환자 등록 소프트웨어 시장에 어떤 영향을 미치는가?
맞춤형 의료에 대한 수요 증가와 환자 중심 케어 모델의 상승은 환자 등록 소프트웨어 시장의 성장에 영향을 미치는 중요한 요소입니다. 의료가 획일적인 접근 방식에서 보다 개인화된 케어 모델로 전환함에 따라 종합적인 환자 데이터의 필요성이 가장 중요해지고 있습니다. 오늘날의 환자는 자신의 케어에 관여하고 특정 건강 이력, 유전적 배경, 라이프 스타일에 기초한 맞춤형 치료 계획을 기대하고 있습니다. 환자 등록 소프트웨어는 의사가 보다 정확한 진단 및 치료 정책을 결정할 수 있도록 하는 상세한 종단 데이터를 제공함으로써 이러한 변화에 중요한 역할을 합니다. 게다가, 웨어러블 디바이스와 모바일 헬스 용도의 등장은 환자 데이터의 소스를 확대하고, 레지스트리 시스템에 공급하며, 전통적인 임상 장소 이외에도 환자의 건강에 대한 실시간 통찰력을 제공합니다. 이러한 추세는 레지스트리 소프트웨어 사용의 한계를 더욱 확대하고 만성 질환 관리를 지속적으로 모니터링하고 의료 제공에 대한보다 적극적인 접근을 촉진합니다. 맞춤형 의료에 대한 소비자의 기대가 높아짐에 따라 이러한 진화하는 의료 모델을 지원하는 레지스트리 솔루션에 대한 수요도 커지고 있습니다.
환자 등록 소프트웨어 시장의 성장을 가속하는 요인이란?
환자 등록 소프트웨어 시장 성장의 원동력은 의료 데이터의 관리와 활용을 근본적으로 재구성하는 몇 가지 요인입니다. 주요 요인 중 하나는 만성 질환 증가와 이에 따른 장기적인 환자 추적의 필요성이며, 이는 의료 기관에 고급 레지스트리 소프트웨어 솔루션을 채택하도록 촉구하고 있습니다. 게다가, 특히 종양학, 심장병학, 희귀질환 등의 분야에서의 임상 연구 활동 증가는 장기간에 걸쳐 환자 데이터의 수집 및 분석을 지원하는 견고한 레지스트리 시스템에 대한 수요를 촉진하고 있습니다. 클라우드 컴퓨팅 및 AI 통합과 같은 기술적 진보로 시설 간의 실시간 데이터 공유 및 협업을 촉진하는 확장 가능하고 안전한 솔루션이 가능해 시장의 보급을 더욱 촉진하고 있습니다. 데이터 투명성과 GDPR(EU 개인정보보호규정) 및 HIPAA와 같은 세계 의료 표준을 준수해야 하는 규제 요건은 또한 데이터의 안전성과 무결성을 보장하는 신뢰할 수 있는 레지스트리 소프트웨어에 대한 투자를 의료 기관에 촉구합니다. 또한 비용을 절감하면서 환자 결과를 개선하는 데 중점을 둔 가치 기반 케어 모델로의 전환으로 데이터 중심의 통찰력에 대한 요구가 높아졌으며 환자 등록 소프트웨어는 의료 제공 최적화와 정밀의료 추진에 필수적인 도구로 자리 잡고 있습니다.
조사 대상 기업 예(총 42사)
Dacima Software, Inc.
Evado Pty. Ltd.
FIGmd, Inc.
Global Vision Technologies, Inc.
Ifa Systems AG
Imagetrend, Inc.
Liaison Technologies
M2S, Inc.
McKesson Corporation
Optum, Inc.
Velos, Inc.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
BJH
영문 목차
영문목차
Global Patient Registry Software Market to Reach US$3.8 Billion by 2030
The global market for Patient Registry Software estimated at US$1.7 Billion in the year 2023, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 11.7% over the analysis period 2023-2030. Product Registries, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$992.9 Million by the end of the analysis period. Growth in the Health Service Registries segment is estimated at 11.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$466.1 Million While China is Forecast to Grow at 10.9% CAGR
The Patient Registry Software market in the U.S. is estimated at US$466.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$575.6 Million by the year 2030 trailing a CAGR of 10.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.3% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.
How Is Technology Revolutionizing the Patient Registry Software Market?
The patient registry software market is undergoing a significant transformation due to advances in technology, which are enabling healthcare organizations to collect, analyze, and utilize vast amounts of patient data more efficiently. Traditionally, patient registries were manual or paper-based systems, which posed challenges in data accuracy, accessibility, and scalability. Today, cloud-based patient registry software solutions have revolutionized how patient data is managed, offering healthcare providers real-time access to comprehensive databases. These systems enable the collection of structured data on demographics, treatments, outcomes, and even genetic information, empowering healthcare providers to make informed decisions that improve patient outcomes. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) algorithms within these software solutions is enhancing predictive analytics capabilities, allowing for early detection of diseases, treatment efficacy analysis, and personalized patient care strategies. This technological shift is not only streamlining operations in hospitals and research institutions but also driving advancements in public health surveillance and clinical research.
Why Are Healthcare Providers Embracing Patient Registry Software?
The adoption of patient registry software is becoming increasingly critical for healthcare providers, as it enhances the ability to track patient outcomes, monitor treatment effectiveness, and comply with regulatory requirements. Hospitals, research organizations, and specialty clinics are leveraging registry software to manage chronic disease populations, track clinical trial participants, and collect data for population health management. These systems enable healthcare providers to build disease-specific registries, such as for cancer, diabetes, or cardiovascular diseases, ensuring that patient care is optimized through detailed tracking and analytics. Moreover, the use of patient registry software helps healthcare organizations comply with various regulations such as HIPAA in the United States and GDPR in Europe, by ensuring the secure and compliant storage of patient information. The ability to share registry data with regulatory bodies and research organizations is further enhancing the role of these systems in fostering collaboration across the healthcare ecosystem. By streamlining data collection and reporting, patient registry software is also contributing to improved clinical decision-making and the overall quality of care provided to patients.
How Are Consumer and Industry Trends Influencing the Patient Registry Software Market?
The increasing demand for personalized medicine and the rise in patient-centric care models are significant factors influencing the growth of the patient registry software market. As healthcare shifts from a one-size-fits-all approach to a more individualized care model, the need for comprehensive patient data has become paramount. Patients today are more involved in their own care, expecting tailored treatment plans based on their specific health history, genetic background, and lifestyle. Patient registry software plays a crucial role in this shift by providing detailed longitudinal data that enables physicians to make more precise diagnoses and treatment decisions. In addition, the rise of wearable devices and mobile health applications is expanding the sources of patient data, feeding into registry systems and providing real-time insights into patient health outside of traditional clinical settings. This trend is further pushing the boundaries of how registry software is used, enabling continuous monitoring of chronic disease management and fostering a more proactive approach to healthcare delivery. As consumer expectations for personalized care grow, so too does the demand for registry solutions that support these evolving healthcare models.
What Factors Are Driving Growth in the Patient Registry Software Market?
The growth in the patient registry software market is driven by several factors that are fundamentally reshaping healthcare data management and utilization. One of the primary drivers is the increasing prevalence of chronic diseases and the subsequent need for long-term patient tracking, which is pushing healthcare organizations to adopt sophisticated registry software solutions. Additionally, the rise in clinical research activities, particularly in fields like oncology, cardiology, and rare diseases, is fueling demand for robust registry systems that can support patient data collection and analysis over extended periods. Technological advancements, such as the integration of cloud computing and AI, are enabling scalable and secure solutions that facilitate real-time data sharing and collaboration across institutions, further driving market adoption. Regulatory requirements for data transparency and compliance with global health standards, such as the GDPR and HIPAA, are also compelling healthcare providers to invest in reliable registry software that ensures data security and integrity. Furthermore, the shift towards value-based care models, which focus on improving patient outcomes while reducing costs, is creating a growing need for data-driven insights, positioning patient registry software as an essential tool in optimizing healthcare delivery and advancing precision medicine.
Select Competitors (Total 42 Featured) -
Dacima Software, Inc.
Evado Pty. Ltd.
FIGmd, Inc.
Global Vision Technologies, Inc.
Ifa Systems AG
Imagetrend, Inc.
Liaison Technologies
M2S, Inc.
McKesson Corporation
Optum, Inc.
Velos, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Patient Registry Software - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Emphasis on Data-Driven Healthcare Drives Growth of Patient Registry Software Solutions
Rising Adoption of EHR and Data Integration Solutions Expands Market for Interoperable Patient Registry Software
Growing Focus on Population Health Management Propels Demand for Comprehensive Patient Registry Solutions
Advancements in AI and Machine Learning Strengthen Predictive Analytics Capabilities in Patient Registry Software
Increased Demand for Real-World Evidence (RWE) in Clinical Research Expands Opportunities for Patient Registry Software in Drug Development
Rising Regulatory Requirements for Patient Data Collection and Reporting Drives Adoption of Registry Solutions for Compliance
Growing Focus on Chronic Disease Management Expands Market for Condition-Specific Patient Registry Systems
Emergence of Cloud-Based and SaaS Models Strengthens the Scalability of Patient Registry Software Solutions
Technological Advancements in Big Data Analytics Enhance the Role of Patient Registries in Personalized Medicine
Increased Use of Patient Registry Software for Longitudinal Studies in Healthcare Drives Demand in Clinical Trials
Rising Importance of Patient-Centric Care Models Expands the Market for Software Solutions that Support Multi-Stakeholder Data Access
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Patient Registry Software Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Patient Registry Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Patient Registry Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Patient Registry Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Product Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Product Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Product Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Health Service Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Health Service Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Health Service Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Disease Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Disease Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Disease Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Medical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Hospitals & Medical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Hospitals & Medical Practices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Pharma, Biotech & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Pharma, Biotech & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Pharma, Biotech & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Government Organizations & TPAs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Government Organizations & TPAs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Government Organizations & TPAs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 35: Canada Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 47: China Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 53: Europe Recent Past, Current & Future Analysis for Patient Registry Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Patient Registry Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Patient Registry Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 62: France Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 65: France Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 68: Germany Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 71: Germany Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 77: Italy Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 80: UK Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 83: UK Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Europe 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Asia-Pacific 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of World Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of World 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
TABLE 101: Rest of World Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of World Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of World 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
